Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,689,041 | $1,851,642 | $2,138,779 | $2,944,257 |
| Short-Term Investments | $868,417 | $414,184 | $1,311,642 | $981,157 |
| Receivables | $1,277,844 | $1,274,530 | $1,625,964 | $1,543,447 |
| Inventory | $5,393,947 | $6,654,111 | $6,843,906 | $4,707,549 |
| Other Curr. Assets | $392,025 | $409,437 | $469,355 | $593,244 |
| Total Curr. Assets | $9,621,274 | $10,603,905 | $12,389,647 | $10,769,653 |
| Property Plant & Equip (Net) | $2,647,675 | $2,634,225 | $2,477,289 | $2,537,157 |
| Goodwill | $2,357,034 | $2,322,375 | $2,350,992 | $2,152,201 |
| Intangibles | $405,515 | $493,216 | $571,656 | $586,671 |
| Long-Term Investments | $955,076 | $2,099,794 | $1,152,465 | $1,636,692 |
| Tax Assets | $282,510 | $320,503 | $139,649 | $121,718 |
| Other NC Assets | $1,074,440 | $729,398 | $1,732,508 | $1,304,083 |
| Total NC Assets | $7,722,250 | $8,599,511 | $8,424,559 | $8,338,522 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17,343,524 | $19,203,415 | $20,814,207 | $19,108,175 |
| Liabilities | – | – | – | – |
| Payables | $299,692 | $302,223 | $427,433 | $385,787 |
| Short-Term Debt | $1,838,944 | $1,880,741 | $4,056,474 | $1,886,285 |
| Tax Payable | $153,508 | $195,736 | $141,770 | $158,719 |
| Deferred Revenue | $0 | $0 | $433,884 | $1,101,993 |
| Other Curr. Liab. | $1,407,093 | $2,607,481 | $516,236 | $1,258,686 |
| Total Curr. Liab. | $3,699,237 | $4,986,180 | $5,575,796 | $4,791,470 |
| LT Debt | $1,138,818 | $1,900,438 | $2,407,429 | $2,354,271 |
| Deferred Rev, NC | $27,285 | $0 | $32,547 | $16,673 |
| Deferred Tax Liab, NC | $242,494 | $0 | $328,920 | $275,358 |
| Other NC Liab. | $33,569 | $328,419 | $61,873 | $147,089 |
| Total NC Liab. | $1,442,166 | $2,228,857 | $2,830,768 | $2,793,390 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $57,770 | $90,417 | $110,749 | $104,001 |
| Total Liabilities | $5,141,403 | $7,215,037 | $8,406,564 | $7,584,860 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,467,296 | $1,467,296 | $1,467,296 | $1,467,296 |
| Retained Earnings | $4,588,064 | $3,385,946 | $4,314,107 | $4,183,761 |
| AOCI | -$1,435,564 | $158,456 | $0 | -$183,356 |
| Other Equity | $7,528,877 | $6,901,451 | $6,531,342 | $5,943,653 |
| Total Equity | $12,148,673 | $11,913,149 | $12,310,919 | $11,411,354 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $53,448 | $75,229 | $96,724 | $111,961 |
| Total Liab. & Tot. Equity | $17,343,524 | $19,203,415 | $20,814,207 | $19,108,175 |
| Net Debt | $1,288,721 | $1,929,537 | $4,325,123 | $1,296,298 |